Home

Venmax Drugs & Pharmaceuticals Ltd EPS

Image

Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAXDRUGS

EPS

₹ -1.42

Last updated on: May 09, 2025

Key Highlights

  • The Earning per Share of Venmax Drugs & Pharmaceuticals Ltd is ₹ -1.42 as of 09 May 25 .
  • The earning per share of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.03 to ₹ 1.49 over 8 quarters. This represents a CAGR of 604.75% .

Historical Earning per Share of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Venmax Drugs & Pharmaceuticals Ltd

Market Cap

14 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

0.0

Day’s High

29.54

Day’s Low

26.77

DTE

0.0

ROE

-0.2

52 Week High

30.88

52 Week Low

6.27

ROCE

-0.3

Market Price of Venmax Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Venmax Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202527.04
08 May 202528.17
07 May 202527.22
06 May 202527.81
05 May 202527.26
02 May 202526.52
30 Apr 202527.9
29 Apr 202529.21
28 Apr 202527.82
25 Apr 202526.5

SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd

Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd

Market Value

14

Asset Value

Value addition

707.5 X

0

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Venmax Drugs & Pharmaceuticals Ltd14.17
Sun Pharmaceutical Industries Ltd418648
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570

Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Venmax Drugs & Pharmaceuticals Ltd News Hub

Venmax Drugs & Pharmaceuticals to conduct board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au

Read more

16 Aug 24

Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter

Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J

Read more

13 Aug 24

Venmax Drugs & Pharmaceuticals to hold board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au

Read more

03 Aug 24

Venmax Drugs & Pharmaceuticals to hold AGM

Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w

Read more

27 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Venmax Drugs & Pharmaceuticals Ltd

What is the EPS of Venmax Drugs & Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Venmax Drugs & Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Venmax Drugs & Pharmaceuticals Ltd EPS calculated?

The EPS of Venmax Drugs & Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Venmax Drugs & Pharmaceuticals Ltd report its EPS?

Venmax Drugs & Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Venmax Drugs & Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Venmax Drugs & Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Venmax Drugs & Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Venmax Drugs & Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions